• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4年植入期后无并发症的血管外植入式心脏复律除颤器拔除:病例报告

Uncomplicated Extravascular Implantable Cardioverter-Defibrillator Extraction After 4 Years Dwell Time: A Case Report.

作者信息

de Veld Jolien A, Kooiman Kirsten M, Knops Reinoud E

机构信息

Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, The Netherlands.

出版信息

J Cardiovasc Electrophysiol. 2025 Jan;36(1):298-300. doi: 10.1111/jce.16530. Epub 2024 Dec 18.

DOI:10.1111/jce.16530
PMID:39696748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11727012/
Abstract

The extravascular implantable cardioverter-defibrillator (EV-ICD) was developed to overcome complications associated with transvenous leads while being able to deliver anti-tachycardia pacing (ATP). The lead is implanted in the substernal space, which makes extraction a cautious procedure. We present a case of a 51-year-old women with a successful EV-ICD extraction after a lead dwell time of 4 years, which is the longest reported. The EV-ICD lead was extracted using simple traction after the removal of all adhesions at the xiphoidal site around the lead. We advise to only use extraction tools if the initial attempt is not successful and if no adhesions at the caudal part of the lead are visible anymore, as these tools could also damage the surrounding tissue and the lead.

摘要

血管外植入式心脏复律除颤器(EV-ICD)的研发旨在克服经静脉导线相关并发症,同时具备发放抗心动过速起搏(ATP)的能力。该导线植入胸骨后间隙,这使得拔除成为一个谨慎的操作过程。我们报告一例51岁女性患者,在导线植入4年后成功拔除EV-ICD,这是有报道以来最长的导线留置时间。在去除剑突部位导线周围所有粘连后,通过简单牵引拔除了EV-ICD导线。我们建议,只有在初次尝试不成功且导线尾部不再可见粘连时才使用拔除工具,因为这些工具也可能损伤周围组织和导线。

相似文献

1
Uncomplicated Extravascular Implantable Cardioverter-Defibrillator Extraction After 4 Years Dwell Time: A Case Report.4年植入期后无并发症的血管外植入式心脏复律除颤器拔除:病例报告
J Cardiovasc Electrophysiol. 2025 Jan;36(1):298-300. doi: 10.1111/jce.16530. Epub 2024 Dec 18.
2
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.经长期随访的血管外植入式心脏复律除颤器的性能与安全性:关键研究的最终结果
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
3
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies.胸骨下除颤导线综合分析:EV ICD Pilot、Pivotal 和持续接入研究的经验。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae225.
4
Oldest-in-Human Successful Extraction Experience of a Novel Substernal Extravascular Defibrillator.新型胸骨下血管外除颤器在人类中的最年长成功植入经验
J Cardiovasc Electrophysiol. 2025 Jan;36(1):295-297. doi: 10.1111/jce.16511. Epub 2024 Nov 22.
5
Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing.评估一种带有胸壁脉冲发生器的第二代肋间血管外植入式心脏复律除颤器导线用于感知、除颤和抗心动过速起搏的性能。
Europace. 2025 Mar 5;27(3). doi: 10.1093/europace/euaf044.
6
Three-year extraction experience of a novel substernal extravascular defibrillation lead in sheep.新型胸骨下血管外除颤电极导线在绵羊体内 3 年的取出经验。
Pacing Clin Electrophysiol. 2022 Mar;45(3):314-322. doi: 10.1111/pace.14451. Epub 2022 Feb 8.
7
Technique for subcutaneous implantable cardioverter-defibrillator extraction.皮下植入式除颤器取出技术。
J Cardiovasc Electrophysiol. 2019 May;30(5):789-791. doi: 10.1111/jce.13893. Epub 2019 Mar 7.
8
Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.经静脉取出起搏器和植入式心脏复律除颤器导线的结果和所需工具比较:单一大容量中心经验的见解。
J Cardiovasc Electrophysiol. 2024 Jul;35(7):1382-1392. doi: 10.1111/jce.16294. Epub 2024 May 9.
9
Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease.经静脉除颤器导线拔除术在终末期肾病患者中的程序结局和长期生存。
Europace. 2017 Dec 1;19(12):1994-2000. doi: 10.1093/europace/euw367.
10
Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.10 年以上植入式心律转复除颤器导线的机械拔除:来自单一高容量中心的见解。
Europace. 2023 Mar 30;25(3):1100-1109. doi: 10.1093/europace/euac272.

本文引用的文献

1
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.经长期随访的血管外植入式心脏复律除颤器的性能与安全性:关键研究的最终结果
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
2
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies.胸骨下除颤导线综合分析:EV ICD Pilot、Pivotal 和持续接入研究的经验。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae225.
3
Transvenous Lead Extraction: Work in Progress.
经静脉导线拔除术:进展中的工作。
Eur Cardiol. 2023 Jun 19;18:e44. doi: 10.15420/ecr.2023.06. eCollection 2023.
4
Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.在临床实践中皮下植入式心律转复除颤器取出术的程序、管理和结果。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad158.
5
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
6
Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.经静脉植入式心脏除颤器导线相关并发症的危险因素和时间趋势。
J Am Heart Assoc. 2018 May 10;7(10):e007691. doi: 10.1161/JAHA.117.007691.
7
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.心脏植入式电子设备植入后的并发症:丹麦全国完整队列分析
Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.
8
An entirely subcutaneous implantable cardioverter-defibrillator.一种完全皮下植入式心脏复律除颤器。
N Engl J Med. 2010 Jul 1;363(1):36-44. doi: 10.1056/NEJMoa0909545. Epub 2010 May 12.
9
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.